Nirav R. Shah, MD, MPH, is Senior Scholar at Stanford University’s Clinical Excellence Research Center. He is a leader in patient safety and quality, innovation and digital health, and the strategies required to transition to lower-cost, patient-centered health care. Board-certified in Internal Medicine, Dr. Shah is a graduate of Harvard College and Yale School of Medicine, and is an elected member of the National Academy of Medicine. He serves as an independent director for STERIS plc, as trustee for The John A. Hartford Foundation, as Senior Fellow of the Institute for Healthcare Improvement (IHI), and as a member of the HHS Secretary's Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2030. Previously, he served as senior vice president and Chief Operating Officer for clinical operations for Kaiser Permanente in Southern California, and as Commissioner of the New York State Department of Health.
- Internal Medicine
Adjunct Professor, Medicine - Primary Care and Population Health
Boards, Advisory Committees, Professional Organizations
Trustee, John A Hartford Foundation (2017 - Present)
Independent Director, STERIS plc (2018 - Present)
Chairman of the Board, Linux Foundation Public Health (2021 - Present)
Board Certification: American Board of Internal Medicine, Internal Medicine (2001)
Residency: Yale University Internal Medicine Residency (2001) CT
AB, Harvard College
MD, MPH, Yale University
- An Impact-Oriented Approach to Epidemiological Modeling. Journal of general internal medicine 2020
Health Care in 2030: Will Artificial Intelligence Replace Physicians?
Annals of internal medicine
View details for PubMedID 30802901
Build vs. Buy: What Should Health Systems Do?
New England Journal of Medicine.
; Care Redesign
Full stack solutions are coming to health careNEJM Catalyst
- Predictive Analytics to Determine Next Year’s Highest-Cost Patients New England Journal of Medicine. 2017 ; NEJM Catalyst
- Healthcare's missing quality measure: time Harvard Business Review. 2017 ; Harvard Business Review
- Health Care That Targets Unmet Social Needs New England Jounal of Medicine. 2016 ; NEJM Catalyst
- Predicting Environmental Allergies from Real World Data Through a Mobile Study Platform. Journal of asthma and allergy 2021; 14: 259–64
Achieving a Quintuple Aim for Telehealth in Pediatrics.
Pediatric clinics of North America
2020; 67 (4): 683–705
Pediatric practice increasingly involves providing care for children with medical complexity. Telehealth offers a strategy for providers and health care systems to improve care for these patients and their families. However, lack of awareness related to the unintended negative consequences of telehealth on vulnerable populations--coupled with failure to intentional design best practices for telehealth initiatives--implies that these novel technologies may worsen health disparities in the long run. This article reviews the positive and negative implications of telehealth. In addition, to achieve optimal implementation of telehealth, it discusses 10 considerations to promote optimal care of children using these technologies.
View details for DOI 10.1016/j.pcl.2020.04.015
View details for PubMedID 32650867
Impact of Social Needs Navigation on Utilization Among High Utilizers in a Large Integrated Health System: a Quasi-experimental Study.
Journal of general internal medicine
BACKGROUND: Programs addressing social determinants of health for high-utilizing patients are gaining interest among health systems as an avenue to promote health and decrease utilization.OBJECTIVE: To evaluate impacts of a social needs screening and navigation program for adult predicted high utilizers on total medical visit utilization.DESIGN: A prospective, quasi-experimental study using an intent-to-treat propensity-weighted difference-in-differences approach. Stratified analyses assessed intervention effects among three low-socioeconomic status sub-samples: patients in low-income areas, in low-education areas, and with Medicaid insurance.PARTICIPANTS: Predicted high utilizers-patients predicted to be in the highest 1% for total utilization in a large integrated health system.INTERVENTION: A telephonic social needs screening and navigation program.MAIN MEASURES: Primary difference-in-difference analyses compared total visit count utilization, including outpatient, emergency department (ED), and inpatient utilization, between the intervention and control groups at both in-network and out-of-network facilities. Prevalence of social needs among sample patients and their connection rates to social needs resources are also described.KEY RESULTS: The study included 34,225 patients (7107 intervention, 27,118 control). Most (53%) patients screened reported social needs, but only a minority (10%) of those with a need were able to connect with resources to address these needs. Primary analysis found total utilization visits decreased 2.2% (95% CI -4.5%, 0.1%; p=0.058) in the intervention group. Stratified analyses showed decreases in total utilization for all low-socioeconomic status subgroups receiving the intervention compared with controls: -7.0% (95% CI -11.9%, -1.9%; p=0.008) in the low-income area group, -11.5% (-17.6%, 5.0%; p<0.001) in the low-education area group, and -12.1% (-18.1%, -5.6%; p<0.001) in the Medicaid group.CONCLUSIONS: Social needs navigation programs for high-utilizing patients may have modest effects on utilization for the population overall. However, significant decreases in utilization were found among low-socioeconomic status patients more likely to experience social needs.
View details for DOI 10.1007/s11606-019-05123-2
View details for PubMedID 31228054
Segmentation of High-Cost Adults in an Integrated Healthcare System Based on Empirical Clustering of Acute and Chronic Conditions
JOURNAL OF GENERAL INTERNAL MEDICINE
2018; 33 (12): 2171–79
High-cost patients are a frequent focus of improvement projects based on primary care and other settings. Efforts to characterize high-cost, high-need patients are needed to inform care planning, but such efforts often rely on a priori assumptions, masking underlying complexities of a heterogenous population.To define recognizable subgroups of patients among high-cost adults based on clinical conditions, and describe their survival and future spending.Retrospective observational cohort study.Within a large integrated delivery system with 2.7 million adult members, we selected the top 1% of continuously enrolled adults with respect to total healthcare expenditures during 2010.We used latent class analysis to identify clusters of alike patients based on 53 hierarchical condition categories. Prognosis as measured by healthcare spending and survival was assessed through 2014 for the resulting classes of patients.Among 21,183 high-cost adults, seven clinically distinctive subgroups of patients emerged. Classes included end-stage renal disease (12% of high-cost population), cardiopulmonary conditions (17%), diabetes with multiple comorbidities (8%), acute illness superimposed on chronic conditions (11%), conditions requiring highly specialized care (14%), neurologic and catastrophic conditions (5%), and patients with few comorbidities (the largest class, 33%). Over 4 years of follow-up, 6566 (31%) patients died, and survival in the classes ranged from 43 to 88%. Spending regressed to the mean in all classes except the ESRD and diabetes with multiple comorbidities groups.Data-driven characterization of high-cost adults yielded clinically intuitive classes that were associated with survival and reflected markedly different healthcare needs. Relatively few high-cost patients remain persistently high cost over 4 years. Our results suggest that high-cost patients, while not a monolithic group, can be segmented into few subgroups. These subgroups may be the focus of future work to understand appropriateness of care and design interventions accordingly.
View details for PubMedID 30182326
View details for PubMedCentralID PMC6258619
- Putting the Health of Communities and Populations First JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 2016; 316 (16): 1649-1650
Redesigning the Regulatory Framework for Ambulatory Care Services in New York
2014; 92 (4): 776-795
Policy Points: The landscape of ambulatory care services in the United States is rapidly changing on account of payment reform, primary care transformation, and the rise of convenient care options such as retail clinics. New York State has undertaken a redesign of regulatory policy for ambulatory care rooted in the Triple Aim (better health, higher-quality care, lower costs)-with a particular emphasis on continuity of care for patients. Key tenets of the regulatory approach include defining and tracking the taxonomy of ambulatory care services as well as ensuring that convenient care options do not erode continuity of care for patients.While hospitals remain important centers of gravity in the health system, services are increasingly being delivered through ambulatory care. This shift to ambulatory care is giving rise to new delivery structures, such as retail clinics and urgent care centers, as well as reinventing existing ambulatory care capacity, as seen with the patient-centered medical home model and the movement toward team-based care. To protect the public's interests, oversight of ambulatory care services must keep pace with these rapid changes. With this purpose, in January 2013 the New York Public Health and Health Planning Council undertook a redesign of the regulatory framework for the state's ambulatory care services. This article describes the principles undergirding the framework as well as the regulatory recommendations themselves.We explored and analyzed the regulation of ambulatory care services in New York in accordance with the available gray and peer-reviewed literature and legislative documents. The deliberations of the Public Health and Health Planning Council informed our review.The vision of high-performing ambulatory care should be rooted in the Triple Aim (better health, higher-quality care, lower costs), with a particular emphasis on continuity of care for patients. There is a pressing need to better define the taxonomy of ambulatory care services. From the state government's perspective, this clarification requires better reporting from new health care entities (eg, retail clinics), connections with regional and state health information technology hubs, and coordination among state agencies. A uniform nomenclature also would improve consumers' understanding of rights and responsibilities. Finally, the regulatory mechanisms employed-from mandatory reporting to licensure to regional planning to the certificate of need-should remain flexible and match the degree of consensus regarding the appropriate regulatory path.Few other states have embarked on a wide-ranging assessment of their regulation of ambulatory care services. By moving toward adopting the regulatory approach described here, New York aims to balance sound oversight with pluralism and innovation in health care delivery.
View details for DOI 10.1111/1468-0009.12092
View details for Web of Science ID 000346588500013
View details for PubMedID 25492604
View details for PubMedCentralID PMC4266176
- Liberating Data to Transform Health Care New York's Open Data Experience JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 2014; 311 (24): 2481-2482
- Housing as Health Care - New York's Boundary-Crossing Experiment NEW ENGLAND JOURNAL OF MEDICINE 2013; 369 (25): 2374-2377
- Managing the Human Toll Caused by Seasonal Influenza New York State's Mandate to Vaccinate or Mask JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 2013; 310 (17): 1797-1798
- Should Health Care Systems Become Insurers? JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 2013; 310 (15): 1561-1562
- Managing Potential Conflicts of Interest in State Medicaid Pharmacy and Therapeutics Committees Seeking Harmony JAMA INTERNAL MEDICINE 2013; 173 (5): 344-344
Methodological Controversies from Comparative Effectiveness (CE) Studies Using Claims vs. Electronic Health Record (EHR) Data
WILEY-BLACKWELL. 2010: S16–S17
View details for Web of Science ID 000209826200038
Pinch and elbow extension restoration in people with tetraplegia: a systematic review of the literature.
journal of hand surgery
2009; 34 (4): 692-699
We conducted a systematic review of the literature to summarize the available data on reconstructive surgeries involving pinch reconstruction and elbow extension restoration in people with tetraplegia.English-language and French-language articles and abstracts published between 1966 and February 2007, identified through MEDLINE and EMBASE searches, bibliography review, and expert consultation, were reviewed for original reports of outcomes with pinch reconstruction and elbow extension restoration in tetraplegic patients after a spinal cord injury. Two reviewers independently extracted data on patient characteristics, surgical methods, and patient outcomes.Our search identified 765 articles, of which 37 met eligibility criteria (one article contained information on both elbow and pinch procedures). Results from 377 pinch reconstructions in 23 studies and 201 elbow extension restorations in 14 studies were summarized. The mean Medical Research Council score for elbow extension went from 0 to 3.3 after reconstruction. The overall mean postoperative strength measured after surgery for pinch reconstruction was 2 kg.More than 500 patients having these procedures experienced a clinically important improvement for both procedures-one restoring elbow extension, and the other, pinch strength. Upper-limb surgeries markedly improved the hand function of people with tetraplegia.Therapeutic IV.
View details for DOI 10.1016/j.jhsa.2008.12.002
View details for PubMedID 19345872
View details for PubMedCentralID PMC2794307
- Utility of different lipid measures to predict coronary heart disease JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 2008; 299 (1): 35-36
- Biomarkers for prediction of cardiovascular events NEW ENGLAND JOURNAL OF MEDICINE 2007; 356 (14): 1473-1474
Bridging the inferential gap: The electronic health record and clinical evidence
2007; 26 (2): W181-W191
Most clinical decisions involve bridging the inferential gap: Clinicians are required to "fill in" where they lack knowledge or where no knowledge yet exists. In this context we consider how the inferential gap is a product, in part, of how knowledge is created, the limits to gaining access to such knowledge, and the variable ways in which knowledge is translated into decisions. We consider how electronic health records (EHRs) will help narrow this gap by accelerating the creation of evidence relevant to everyday practice needs and facilitating real-time use of knowledge in practice.
View details for DOI 10.1377/hlthaff.26.2.w181
View details for Web of Science ID 000244763500057
View details for PubMedID 17259202
View details for PubMedCentralID PMC2670472
- What is the best evidence for making clinical decisions? JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 2000; 284 (24): 3127-3127
Randomized, controlled trials, observational studies, and the hierarchy of research designs.
NEW ENGLAND JOURNAL OF MEDICINE
2000; 342 (25): 1887-1892
In the hierarchy of research designs, the results of randomized, controlled trials are considered to be evidence of the highest grade, whereas observational studies are viewed as having less validity because they reportedly overestimate treatment effects. We used published meta-analyses to identify randomized clinical trials and observational studies that examined the same clinical topics. We then compared the results of the original reports according to the type of research design.A search of the Medline data base for articles published in five major medical journals from 1991 to 1995 identified meta-analyses of randomized, controlled trials and meta-analyses of either cohort or case-control studies that assessed the same intervention. For each of five topics, summary estimates and 95 percent confidence intervals were calculated on the basis of data from the individual randomized, controlled trials and the individual observational studies.For the five clinical topics and 99 reports evaluated, the average results of the observational studies were remarkably similar to those of the randomized, controlled trials. For example, analysis of 13 randomized, controlled trials of the effectiveness of bacille Calmette-Guérin vaccine in preventing active tuberculosis yielded a relative risk of 0.49 (95 percent confidence interval, 0.34 to 0.70) among vaccinated patients, as compared with an odds ratio of 0.50 (95 percent confidence interval, 0.39 to 0.65) from 10 case-control studies. In addition, the range of the point estimates for the effect of vaccination was wider for the randomized, controlled trials (0.20 to 1.56) than for the observational studies (0.17 to 0.84).The results of well-designed observational studies (with either a cohort or a case-control design) do not systematically overestimate the magnitude of the effects of treatment as compared with those in randomized, controlled trials on the same topic.
View details for Web of Science ID 000087704700007
View details for PubMedID 10861325
View details for PubMedCentralID PMC1557642